Page 65 - e-CPG-SLE-8_5_24
P. 65

Management of Systemic Lupus Erythematosus

               Life,  International  Systemic  Lupus  Erythematosus  Cohort.  Arthritis  Care  Res
               (Hoboken). 2015;67(8):1180-1185.
           37.  Selvananda  S,  Kan  SL.  Performance  of  the  2019  European  League  Against
               Rheumatism/American  College  of  Rheumatology  classification  criteria  for
               systemic lupus erythematosus in a multiethnic Malaysian cohort. Int J Rheum
               Dis. 2021;25(2):131-139.
           38.  Ruperto  N,  Hanrahan  LM,  Alarcón  GS,  et  al.  International  consensus  for  a
               definition of disease flare in lupus. Lupus. 2011;20(5):453-462.
           39.  Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women
               with systemic lupus erythematosus. N Engl J Med. 2005;353(24):2550-2558.
           40.  Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease
               activity index 2000. J Rheumatol. 2002;29(2):288-291.
           41.  van  Vollenhoven  RF,  Bertsias  G,  Doria  A,  et  al.  2021  DORIS  definition  of
               remission in SLE: final recommendations from an international task force. Lupus
               Sci Med. 2021;8(1):e000538.
           42.  Franklyn K, Lau CS, Navarra SV, et al. Definition and initial validation of a Lupus
               Low Disease Activity State (LLDAS). Ann Rheum Dis. 2015;75(9):1615-1621.
           43.  Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis,
               risk factors and preventive strategies. Mediterr J Rheumatol. 2017;28(1):4-12.
           44.  Szczęch  J,  Samotij  D,  Werth  VP,  et  al.  Trigger  factors  of  cutaneous  lupus
               erythematosus: a review of current literature. Lupus. 2017;26(8):791-807.
           45.  Barbhaiya  M,  Costenbader  KH.  Ultraviolet  radiation  and  systemic  lupus
               erythematosus. Lupus. 2014;23(6):588-595.
           46.  Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College
               of  Rheumatology  Guideline  for  the  Management  of  Reproductive  Health  in
               Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2020;72(4):529-
               556.
           47.  Keeling SO, Vandermeer B, Medina J, et al. Measuring Disease Activity and
               Damage with Validated Metrics: A Systematic Review on Mortality and Damage
               in Systemic Lupus Erythematosus. J Rheumatol. 2018;45(10):1448-1461.
           48.  Murimi-Worstell IB, Lin DH, Nab H, et al. Association between organ damage
               and mortality in systemic lupus erythematosus: a systematic review and meta-
               analysis. BMJ Open. 2020;10(5):e031850.
           49.  Campar  A,  Farinha  F,  Vasconcelos  C.  Refractory  disease  in  systemic  lupus
               erythematosus. Autoimmun Rev. 2011;10(11):685-692.
           50.  Fanouriakis  A,  Kostopoulou  M,  Alunno  A,  et  al.  2019  update  of  the  EULAR
               recommendations for the management of systemic lupus erythematosus. Ann
               Rheum Dis. 2019;78(6):736-745.
           51.  Fairley JL, Oon S, Saracino AM, et al. Management of cutaneous manifestations
               of  lupus  erythematosus:  A  systematic  review.  Semin  Arthritis  Rheum.
               2019;50(1):95-127.
           52.  Xie X, Song Y, Yang H, et al. Effects of transitional care on self-care, readmission
               rates, and quality of life in adult patients with systemic lupus erythematosus: a
               randomized controlled trial. Arthritis Res Ther. 2018;20(1):184.
           53.  Fangtham M, Kasturi S, Bannuru RR, et al. Non-pharmacologic therapies for
               systemic lupus erythematosus. Lupus. 2019;28(6):703-712.
           54.  Frade S, O’Neill S, Greene D, et al. Exercise as adjunctive therapy for systemic
               lupus erythematosus. Cochrane Database Syst Rev. 2023;4(4):CD014816.
           55.  Ratanasiripong NT, Cahill S, Crane C, et al. The Outcomes of an e-Wellness
               Program  for  Lupus  Patients  in  Thailand:  A  Participatory  Action  Research
               Approach. J Prev Med Public Health. 2023;56(2):154-163.
           56.  Mosca M, Tani C, Carli L, et al. Glucocorticoids in systemic lupus erythematosus.
               Clin Exp Rheumatol. 2011;29(5 Suppl 68):S126-S129.

                                      48
   60   61   62   63   64   65   66   67   68   69   70